While there was improvement yet no difference between treatment group and placebo for the FSFI
domains except lubrication, which did improve more in the treatment group, that is in fact important for comfort during vaginal penetration.
is a brief, multidimensional scale for assessing FSD.
21 used a score of 23 out of 36 as the cut-off for diagnosed SD in FSFI
and we used 26.
was the body which ratified women's world records and one of the earliest was a time of 51.
is a validated self-administered questionnaire that consists of 19 questions and measures six domains of sexual function: desire, arousal, lubrication, orgasm, satisfaction and pain (8).
The primary outcome of the study was FSFI
total and subscale scores in patient group in comparison to control group.
Twenty-six participants completed a follow-up FSFI
, with a mean (SD) baseline score of 11.
At the beginning of the study, all of the women's FSFI
scores revealed that the women were struggling with FSD, with average scores of 13.
In the third study, there was statistically significant improvement in the change in sexual desire using the FSFI
Desire domain with flibanserin compared with placebo.
They also found significant negative correlation between total FSFI
score and age, partner age and marriage duration (18).
HAM-D and FSFI
(Female Sexual Function Index) scales were applied.
In a study of 72 women with vulvar disease and 72 controls who completed the Female Sexual Function Index (FSFI
) assessment, the median FSFI
score was 21.